← Back to Ardent Health, Inc.
Stoqly stoqly.net Company report Β· October 27, 2026

Ardent Health, Inc.

ARDT NYSEΒ· Services-General Medical & Surgical Hospitals, Nec

Last close Β· Oct 26, 2026

$12.18

KIRA Β· Stoqly’s AI analyst, in plain words

  • Ardent Health, Inc. had $6.3B of revenue in fiscal 2025, up 6.0% on the year before.
  • Ardent Health, Inc. made $136M of net profit in fiscal 2025. From fiscal 2022 to 2025, diluted EPS grew βˆ’13.8% a year.
  • Ardent Health, Inc. owes $431M more than it holds in cash.

Market cap

$1.7B

P/E

22.1x

Revenue

$6.3B

Net income

$136M

Free cash flow

β€”

Operating margin

β€”

Ardent Health, Inc. in 30 seconds Β· fiscal 2025

Good

Are sales growing?

+6.0%

Yes. Sales grew 6.0% last year.

So-so

Does it make a profit?

2.1%

A little. It keeps 2.1% of every sale as profit.

So-so

How healthy are the accounts?

5 / 8

Mixed. It passes 5 of 8 health tests.

For information

How is the share priced?

22.1x

One share costs 22.1 times its yearly profit per share.

What Ardent Health, Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 16, 2026
Legal name
Ardent Health, Inc.
CIK
0001756655
stoqly.net Β· ARDT Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Ardent Health, Inc. Β· ARDT

Results and finances

The last 4 fiscal years. Amounts in USD.

Fiscal yearFY22FY23FY24FY25
Sales and profit
Revenue $5.1B $5.4B $6.0B $6.3B
Revenue growth β€” 5.5% 10.3% 6.0%
Net income $189M $53.9M $210M $136M
Net margin 3.7% 1.0% 3.5% 2.1%
Diluted EPS $1.50 $0.43 $1.58 $0.96
Cash
Cash from operations βˆ’$38.4M $222M $315M $471M
Dividends paid $175M $0.0M $0.0M β€”
Share count change β€” 0.0% 5.3% 6.6%
Debt and strength
Cash and short-term investments $456M $438M $557M $710M
Debt incl. finance leases β€” $1.2B $1.1B $1.1B
Shareholders' equity $1.0B $671M $1.1B $1.3B
Current ratio β€” 1.6x 1.9x 2.0x
Returns and quality
Return on equity 18.2% 6.3% 23.3% 11.2%
Return on tangible equity 97.0% β€” 75.3% 34.3%
Piotroski F-score β€” β€” 7 5

Insiders bought, 12 months

$0.2M

2 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· ARDT Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Ardent Health, Inc. Β· ARDT

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $12.18 a share, the company is worth $1.7B: 22.1 times its earnings of the last four quarters.

Source: SEC EDGAR XBRL filings (CIK 0001756655). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.